| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8669215 | The Journal of Heart and Lung Transplantation | 2018 | 12 Pages |
Abstract
This study is the first to report an increased proportion of circulating CD4+CD25hiFoxP3+ T cells early post-transplantation in lung recipients who proceed to develop BOS within 3 years, which supports its use as a BOS predictive biomarker.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Maxim PhD, Philippe MD, PhD, Richard PhD, Lola MD, Carole PhD, Eugénie Durand, Gaelle Tilly, Jennifer Loy, Aurore Foureau, Pierre-Joseph PhD, Adrien MD, Antoine MD, PhD, Martine MD, PhD, Romain MD, PhD, Sacha MD, Claire MD, Olivier MD, PhD,